Aclaris Therapeutics, Inc. (ACRS)
3.04
-0.01
(-0.33%)
USD |
NASDAQ |
Mar 03, 15:13
Aclaris Therapeutics EPS Diluted (Quarterly) : -0.1614 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | 1.131 |
| PMV Pharmaceuticals, Inc. | -0.3974 |
| Atea Pharmaceuticals, Inc. | -0.5319 |
| Instil Bio, Inc. | -2.011 |
| Corcept Therapeutics, Inc. | 0.1994 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.80M |
| Revenue (Quarterly) | 1.295M |
| Total Expenses (Quarterly) | 21.09M |
| Enterprise Value | 241.82M |
| Gross Profit Margin (Quarterly) | -13.44% |
| Profit Margin (Quarterly) | -1.53K% |
| Earnings Yield | -17.42% |
| Normalized Earnings Yield | -16.95 |